Sex (n= 167)

(%)

Male

95

(56.9)

Female

72

(43.1)

Age (years)

Total

C. albicans

C. tropicalis

C. parapsilosis

C. glabrata

Candida spp.

(%)

(73.7)

(15.0)

(5.4)

(3.6)

(2.4)

<1

5

(3.0)

5

(3.0)

0

(0.0)

0

(0.0)

0

(0.0)

0

(0.0)

1 to 18

25

(15.0)

15

(9.0)

7

(4.2)

3

(1.8)

0

(0.0)

0

(0.0)

19 to 40

47

(28.1)

38

(22.8)

4

(2.4)

1

(0.6)

4

(2.4)

0

(0.0)

41 to 60

60

(35.9)

43

(25.7)

9

(5.4)

4

(2.4)

1

(0.6)

3

(1.8)

>60

30

(18.0)

22

(13.2)

5

(3.0)

1

(0.6)

1

(0.6)

1

(0.6)

Mean age

41

Isolation sample

Deep infections

BAL

68

(40.7)

56

(33.5)

7

(4.2)

2

(1.2)

2

(1.2)

1

(0.6)

Urine

62

(37.1)

40

(24.0)

13

(7.8)

4

(2.4)

3

(1.8)

2

(1.2)

Blood

8

(4.8)

7

(4.2)

0

(0.0)

1

(0.6)

0

(0.0)

0

(0.0)

Medical devices

3

(1.8)

1

(0.6)

1

(0.6)

1

(0.6)

0

(0.0)

0

(0.0)

Superficial infections

Swabing (genital and pharynx)

11

(6.6)

6

(3.6)

4

(2.4)

0

(0.0)

0

(0.0)

1

(0.6)

Oral cavity

10

(6.0)

9

(5.4)

0

(0.0)

0

(0.6)

1

(0.6)

0

(0.0)

Skin and nail scrapping

5

(3.0)

4

(2.4)

0

(0.0)

1

(0.6)

0

(0.0)

0

(0.0)

Impatient units

Internal Medicine

101

(60.5)

71

(42.5)

14

(8.4)

7

(4.2)

5

(3.0)

4

(2.4)

ICU

57

(34.1)

44

(26.3)

11

(6.6)

1

(0.6)

1

(0.6)

0

(0.0)

Other wards

6

(3.6)

5

(3.0)

0

(0.0)

1

(0.6)

0

(0.0)

0

(0.0)

ER

3

(1.8)

3

(1.8)

0

(0.0)

0

(0.0)

0

(0.0)

0

(0.0)

Underlying diseases

Respiratory diseases

55

(32.9)

43

(25.7)

9

(5.4)

0

(0.0)

2

(1.2)

1

(0.6)

Malignancies

20

(12.0)

13

(7.8)

4

(2.4)

1

(0.6)

1

(0.6)

1

(0.6)

Tuberculosis

10

(6.0)

8

(4.8)

0

(0.0)

0

(0.0)

2

(1.2)

0

(0.0)

Diabetes mellitus

7

(4.2)

6

(3.6)

0

(0.0)

1

(0.6)

0

(0.0)

0

(0.0)

UTI

7

(4.2)

5

(3.0)

0

(0.0)

0

(0.0)

1

(0.6)

1

(0.6)

Risk factors

CVC

79

(47.3)

61

(36.5)

11

(6.6)

2

(1.2)

3

(1.8)

2

(1.2)

broad-spectrum antimicrobial

33

(19.8)

25

(15.0)

5

(3.0)

1

(0.6)

1

(0.6)

1

(0.6)

Mechanical ventilation

44

(26.3)

35

(21.0)

7

(4.2)

0

(0.0)

1

(0.6)

1

(0.6)

sepsis

43

(25.7)

36

(21.6)

5

(3.0)

1

(0.6)

0

(0.0)

1

(0.6)

previous use of antifungal drugs

21

(12.6)

16

(9.6)

4

(2.4)

1

(0.6)

0

(0.0)

0

(0.0)

HIV/AIDS

10

(6.0)

7

(4.2)

2

(1.2)

0

(0.0)

1

(0.6)

0

(0.0)

Invasive procedures

8

(4.8)

8

(4.8)

1

(0.6)

0

(0.0)

1

(0.6)

0

(0.0)

autoimmunity disorders

7

(4.2)

5

(3.0)

1

(0.6)

1

(0.6)

0

(0.0)

0

(0.0)